Thu, February 13, 2025
[ Thu, Feb 13th 2025 ]: Indiatimes
Top 20 richest families in Asia 2025: Mukesh Amba .. followed by key Indian and Asian business empires
[ Thu, Feb 13th 2025 ]: MSN
Chinese businesses rush to try DeepSeek AI at 'unprecedented' scale
[ Thu, Feb 13th 2025 ]: decrypt
Riot Taps Advisors to Explore AI Partnerships as Bitcoin Miners Eye New Revenue Streams
[ Thu, Feb 13th 2025 ]: Reuters
Commerzbank to cut 3,900 jobs, mainly in Germany, as it fends off UniCredit
[ Thu, Feb 13th 2025 ]: Reuters
Commerzbank to cut 3,900 jobs, mainly in Germany
[ Thu, Feb 13th 2025 ]: Indiatimes
Indian student admissions in Canada are affected .. dean of Alberta School of Business Vikas Mehrotra
[ Thu, Feb 13th 2025 ]: MSN
'Vindicated': Dallas City Council rezones neighborhood that once housed Shingle Mountain
[ Thu, Feb 13th 2025 ]: Yahoo
WEATHER AWARE for Heavy Rain and Severe Storms Tonight - CBS 42 News at 4 pm Weather Update
[ Thu, Feb 13th 2025 ]: MSN
The federal paperwork mine in DOGE's crosshairs is real and bizarre
[ Thu, Feb 13th 2025 ]: citizen
Why are African start-up exits scarce and how can founders better prepare?
[ Thu, Feb 13th 2025 ]: MSN
Is Albertsons Companies, Inc. (ACI) the Cheapest Retail Stock to Buy?
[ Thu, Feb 13th 2025 ]: Reuters
South Korea fines JPMorgan, Nomura, UBS and Morgan Stanley for short selling breaches
Wed, February 12, 2025
[ Wed, Feb 12th 2025 ]: Indiatimes
Top 6 Zodiac signs that attract money like a magnet
[ Wed, Feb 12th 2025 ]: fbcnews
New loan facility to assist women
[ Wed, Feb 12th 2025 ]: Forbes
America And The West Look To Eurasian Energy
[ Wed, Feb 12th 2025 ]: cnbctv18
New Income Tax Bill proposes key changes: 23 chapters, 16 schedules, and taxpayer's charter
[ Wed, Feb 12th 2025 ]: CNBC
Amica life insurance review 2025
[ Wed, Feb 12th 2025 ]: AOL
JPMorgan Chase reportedly to start rounds of layoffs
[ Wed, Feb 12th 2025 ]: TechRepublic
Chase Business Checking Review: Is It Right for You?
[ Wed, Feb 12th 2025 ]: Fortune
'We are a speck of dust': CEO of $80 billion Door .. ls candid take on popular delivery app's standing
[ Wed, Feb 12th 2025 ]: WDSU
Inflation rises as consumer prices surge in January
[ Wed, Feb 12th 2025 ]: manilatimes
Ascendis Pharma Reports Fourth Quarter and Full Year 2024 Financial Results
[ Wed, Feb 12th 2025 ]: Forbes
The Life Insurance Industry Is Misbranded
[ Wed, Feb 12th 2025 ]: AOL
Worried about a market bubble? Here are 4 tips to protect your portfolio now and in the future
[ Wed, Feb 12th 2025 ]: WTNH
What does having the Consumer Financial Protection Bureau on hold mean for consumers?
[ Wed, Feb 12th 2025 ]: Diginomica
From AI to ROI via EX - Freshworks priorities for .. ake shape as revenues rise, losses narrow in 2024
[ Wed, Feb 12th 2025 ]: MSN
The latest merger & acquisition and fundraising news in Welsh business
[ Wed, Feb 12th 2025 ]: Forbes
How Payment Tech Can Help 5 Year-End Financial Pain Points
[ Wed, Feb 12th 2025 ]: MyJoyOnline
UBA Ghana wins 3 awards from Global Business and Finance Magazine
[ Wed, Feb 12th 2025 ]: MSN
Super Micro stock surges after outlining ambitiou .. rgets, assuring investors it will avoid delisting
[ Wed, Feb 12th 2025 ]: TradeWinds
Wallenius Wilhelmsen boasts 'unique' backlog with room to run as trade-choking tariffs loom
[ Wed, Feb 12th 2025 ]: MSN
The market is looking very positively at DOGE and Elon Musk, says Wharton's Jeremy Siegel
[ Wed, Feb 12th 2025 ]: Reuters
Commerzbank plans job cuts, new targets to keep UniCredit away, sources say
[ Wed, Feb 12th 2025 ]: Tuko
APHRC Advertises Field Interviewer Jobs for Form 4 Leavers with KCSE C+, Other Positions
[ Wed, Feb 12th 2025 ]: Reuters
JPMorgan sees investment banking fees rising by mid-teens percentage in first quarter
[ Wed, Feb 12th 2025 ]: CNET
How to Track a Paper Tax Refund Check That's Coming in the Mail
[ Wed, Feb 12th 2025 ]: Reuters
SoftBank's Son back to form with big bets and quarterly loss
[ Wed, Feb 12th 2025 ]: News24
SA will likely wait until 2026 to lower inflation target, investors and analysts say
[ Wed, Feb 12th 2025 ]: Newsroom
'Woke banks' row: Bank reveals $132m exposure to risky petrol stations
Tue, February 11, 2025
[ Tue, Feb 11th 2025 ]: AOL
Super Micro stock drops ahead of business update
[ Tue, Feb 11th 2025 ]: Mint
New Income Tax Bill 2025 Highlights: New I-T bill .. Sabha on Thursday; How will it impact taxpayers?
[ Tue, Feb 11th 2025 ]: MSN
Bank of England to cut interest rates only twice more, NIESR predicts
[ Tue, Feb 11th 2025 ]: MSN
Taurus: Your finance horoscope - February 12
[ Tue, Feb 11th 2025 ]: Reuters
DuPont raises 2025 profit forecast on strong electronics demand
[ Tue, Feb 11th 2025 ]: MSN
The impact of Trump's tariffs is already being felt
[ Tue, Feb 11th 2025 ]: Reuters
Guyana issues 30-day notice to cancel Frontera, CGX Energy's license
[ Tue, Feb 11th 2025 ]: Forbes
Trump Tariffs Live Updates: EU Says It Is Readyin .. ermeasures Against 25% Steel And Aluminum Tariffs
[ Tue, Feb 11th 2025 ]: Forbes
AI Agents Are Coming For Your Industry: Here's Who's First In Line

Ascendis Pharma Reports Fourth Quarter and Full Year 2024 Financial Results

COPENHAGEN, Denmark, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced financial results for the fourth quarter and full year ended December 31, 2024, and provided a business update.
Ascendis Pharma A/S announced its financial results for the fourth quarter and full year of 2024. The company reported total revenue of $157.6 million for the year, with a significant increase attributed to the sales of SKYTROFA, their once-weekly growth hormone therapy, which generated $145.7 million. Despite this, the company experienced a net loss of $580.7 million for the year, largely due to increased operating expenses, including research and development costs which rose to $378.9 million from $298.6 million the previous year. Operating expenses were driven by higher personnel costs, clinical trial expenses, and manufacturing costs for ongoing and future product launches. Ascendis also highlighted progress in their pipeline, with positive developments in treatments like TransCon PTH for hypoparathyroidism and TransCon CNP for achondroplasia, alongside plans for further regulatory submissions and market expansions.

Read the Full manilatimes Article at:
[ https://www.manilatimes.net/2025/02/13/tmt-newswire/globenewswire/ascendis-pharma-reports-fourth-quarter-and-full-year-2024-financial-results/2054927 ]